Michael M. E. Johns, M.D. (Chair), is the chancellor emeritus and a professor of medicine and public health at Emory University. He was previously the executive vice president for health affairs and president, chief executive officer, and chair of Emory Healthcare. He has also served as interim executive vice president for medical affairs at the University of Michigan and vice president of the medical faculty and dean of the Johns Hopkins School of Medicine and has been on the faculty of the University of Virginia and the Walter Reed Army Medical Center. He is a member of the board of the Uniformed Services University of the Health Sciences, the Vanderbilt University Medical Center, and the University of Michigan Health. He has also served on the advisory committee to the director of the Centers for Disease Control and Prevention, as editor of the Archives of Otolaryngology, and on the editorial board of the Journal of the American Medical Association. He received his bachelor’s degree at Wayne State University and graduated with a medical degree with distinction from the University of Michigan, where he also completed his residency training in otolaryngology, head, and neck surgery. He is the former president of the American Board of Otolaryngology. He has served on various boards, including those of AMN Healthcare, Blue Cross and Blue Shield of Maryland, Georgia Cancer Coalition, Johnson & Johnson, and West Health. His numerous honors include the Castle Connolly Lifetime Achievement Award and an honorary doctorate of science from the University of Michigan. He is a member and former vice chair of the council of the National Academy of Medicine.
Katrina Armstrong, M.D., is the Jackson Professor of Clinical Medicine at the Harvard Medical School and the chair of the Department of Medicine and physician-in-chief of Massachusetts General Hospital. Previously she was the chief of the Division of General Internal Medicine, an associate director of the Abramson Cancer Center, and a co-director of the Robert Wood Johnson Clinical Scholars Program at the University of Pennsylvania. She has been a fellow at the Leonard Davis Institute of Health Economics and a senior scholar at the Center for Clinical Epidemiology and Biostatistics at the University of Pennsylvania. She is the chair of the external advisory panel of the Clinical Sequencing Exploratory Research Consortium of the National Human Genome Research Institute. Her honors include the Molly and Sidney N. Zubrow Award and the Robert Austrian Faculty Award from the University of Pennsylvania School of Medicine, the Warfield T. Longcope Prize for Excellence in Clinical Medicine from the Johns Hopkins University School of Medicine, and a Robert Wood Johnson Faculty Scholar Award. She is a graduate of Yale University and the Johns Hopkins University School of Medicine. She is a fellow of the American College of Physicians, a member of the American Society of Clinical Investigation, and a member of the National Academy of Medicine.
Smita Bhatia, M.D., M.P.H., is the Gay and Bew White Endowed Chair in Pediatric Oncology at the University of Alabama School of Medicine, where she is also the director of the Institute for Cancer Outcomes and Survivorship at the University of Alabama School of Medicine. She is also the associate director for outcomes research at the University of Alabama Comprehensive Cancer Center. She has served on the editorial board of the Journal of Clinical Oncology. She obtained her M.B.B.S. and M.D. from the All India Institute of Medical Sciences, where she also completed her internship and residency. She received an M.P.H. from the University of Minnesota and completed her fellowship in blood banking, pediatric hematology/oncology, and bone marrow transplantation. She has served on the board of the American Society of Clinical Oncology. She is an elected member of the Association of American Physicians, the American Pediatric Society, and the American Society for Clinical Investigation.
Betty Ferrell, R.N., Ph.D., is a director and a professor at the City of Hope National Medical Center, where she directs the Division of Nursing Research and Education. She has been the co-chair of the National Consensus Project for Quality Palliative Care led by the National Coalition for Hospice and Palliative Care. She is a co-editor of the Oxford Textbook of Palliative Nursing and the editor-in-chief of the Journal of Hospice & Palliative Nursing. She received a B.S.N. from Central State University, a
Ph.D. from Texas Woman’s University, and an M.A. in theology, ethics, and culture from Claremont Graduate University. She is a recipient of the American Cancer Society Pathfinder Award and was named one of the 30 visionaries in the field of hospice and palliative medicine by the American Academy of Hospice and Palliative Medicine. She has been a member of the board of scientific advisors of the National Cancer Institute and the National Cancer Policy Forum of the National Academies of Sciences, Engineering, and Medicine. She is a fellow of the American Psychosocial Oncology Society, American Academy of Nursing, and Palliative Care Nursing.
Jonathan Fielding, M.D., M.P.H., M.B.A., is a distinguished professor of health policy and management and pediatrics in the Fielding School of Public Health and the Geffen School of Medicine at the University of California, Los Angeles (UCLA). He is the founding co-director of the UCLA Center for Health Enhancement, Education, and Research. He was a founding member of the U.S. Preventive Services Task Force and is the chair of the U.S. Community Preventive Services Task Force. He served as the director of public health and a health officer for Los Angeles County for 16 years. Before that he was the Massachusetts Commissioner of Public Health. He has served as the president and a regent for the American College of Preventive Medicine and as a member of the National Commission on Prevention Priorities as well as on the advisory committee to the California State Department of Public Health. His honors include the Sedgwick Medal for Distinguished Service in Public Health, UCLA Medal, Milton and Ruth Roemer Prize for Creative Local Public Health Work, Fries Prize for Improving Health, Porter Prize for National Impact on Improving the Health of Americans, and Beverlee A. Myers Award for Excellence in Public Health, and he received an honorary fellowship from the Society for Public Health Education. He received his M.D., M.A., and M.P.H. from Harvard University and his M.B.A. from the Wharton School of Business Administration. He is a member of the National Academy of Medicine.
Beverly Ashleigh Guadagnolo, M.D., M.P.H., is a professor of radiation oncology and health services research at The University of Texas MD Anderson Cancer Center where she serves as the section chief of sarcoma/melanoma radiation oncology, and she is the associate director of the Physicians Referral Service. She served as member of the Department of Health and Human Services advisory committee on minority health, the Medicare Evidence Development and Advisory Committee of the Centers for Medicare & Medicaid Services, and on a technical expert panel of the Agency for Healthcare Research and Quality project on radiotherapy
treatments for head and neck cancer. She received a B.A. in biology from The University of Texas at Austin, an M.D. from the Harvard Medical School, and an M.P.H from the Harvard School of Public Health, where she held a National Cancer Institute fellowship in cancer prevention.
Joseph Lipscomb, Ph.D., is the Georgia Cancer Coalition Distinguished Cancer Scholar and a professor of health policy and management at the Rollins School of Public Health at Emory University. Previously he was the associate director for population sciences at Emory’s Winship Cancer Institute and a clinical investigator at the Kaiser Permanente Center for Health Research. He was also on the faculty of Duke University and the University of North Carolina at Chapel Hill, the chief of the Outcomes Research Branch at the National Cancer Institute, and a study director at the National Academies of Sciences, Engineering, and Medicine. He has twice received the National Institutes of Health Award of Merit. He has served as a consultant in health economics, outcomes research, and program evaluation to the American Cancer Society, SRA International, Amgen, Pfizer, Boehringer Ingelheim, Janssen, Dupont Merck, G.D. Searle, the Society of Nuclear Medicine, Burroughs Wellcome, and PhRMA. He is the chair of the Data and Evaluation Committee for the Georgia Cancer Control Consortium and is a member of the American College of Surgeons Commission on Cancer’s Quality Integration Committee, and he was the chair of the American Cancer Society Health Services Research Advisory Committee. He received his B.A. from Vanderbilt University and Ph.D. from the University of North Carolina at Chapel Hill.
María Elena Martínez, Ph.D., M.P.H., is the Sam M. Walton Endowed Chair for Cancer Research and a professor of family medicine and public health at the University of California, San Diego. She also serves as the associate director of population sciences, disparities, and community engagement at the Moores Cancer Center. Previously she was a professor of epidemiology in the Mel and Enid Zuckerman College of Public Health and was the Richard H. Hollen Professor of Cancer Prevention at the University of Arizona Cancer Center. She received a B.S. in nutrition from the University of Illinois and an M.P.H. and a Ph.D. in epidemiology from the University of Texas School of Public Health. She completed a postdoctoral fellowship at the Harvard School of Public Health. She is the senior editor of the cancer disparities section for Cancer Epidemiology, Biomarkers, & Prevention and an associate editor of the Journal of the National Cancer Institute. She has served as the chair of the American Association for Cancer Research’s Minorities in Cancer Research Council. She served as a member of the National Cancer Institute’s Board of Scientific Advisors and was a member of the Cancer Moonshot Blue Ribbon Panel.
Mary McCabe, R.N., M.A., is a consultant in cancer survivorship. She was formerly the clinical director of the Cancer Survivorship Center and the chair of the ethics committee at the Memorial Sloan Kettering Cancer Center. Previously she served as the director of nursing services at the Lombardi Cancer Center at Georgetown University and as a lecturer at Cornell Weill Medical College and the Columbia University School of Nursing. She has been the director of the Offices of Clinical Research Promotion and of Education and Special Initiatives at the National Cancer Institute, where she was also the assistant director of the Division of Cancer Treatment and Diagnosis. She received her B.A. from Trinity College, B.S.N. from Emory University, and M.A. from The Catholic University of America. Her honors include the American Cancer Society Merit Award, Oncology Nursing Society Leadership Award, National Institutes of Health (NIH) Outstanding Performance Award, NIH Director’s Award, and Emory University’s Outstanding Alumnae Award.
Leah Merchant is a section supervisor for the Montana Cancer Control Programs in the Montana Department of Public Health and Human Services. Her responsibilities include managing regional contracts with local public health departments across Montana to implement cancer education outreach and direct screening services and also leading statewide implementations efforts to address cancer policy issues affecting diverse populations. She is the past chair of the cancer council of the National Association of Chronic Disease Directors. She received her B.A. degree from Smith College.
Jewel Mullen, M.D., M.P.H., M.P.A., is the associate dean for healthy equity at the Dell Medical School and an associate professor of population health and internal medicine at The University of Texas at Austin. She is the former principal deputy assistant secretary for health, former acting assistant secretary for health, and former acting director of the National Vaccine Program Office at the Department of Health and Human Services. Previously she served as a commissioner of the Connecticut Department of Public Health. Before that she was the director of the Bureau of Community Health and Prevention at the Massachusetts Department of Public Health and the medical director of Baystate Mason Square Neighborhood Health Center. She has served as a member of the advisory committee to the director of the Centers for Disease Control and Prevention and the chair of the Breast and Cervical Cancer Early Detection and Control Advisory Committee. She serves on the editorial board of Morbidity and Mortality Weekly Report. She began her clinical career as a member of the National Health Service Corps at Bellevue Hospital, New York, after which she joined the medical faculty of the University of Virginia. She has
been a member of the medical staff at the Hospital of St. Raphael, the Yale University Health Services, and Yale New Haven Hospital. She received her B.S. and M.P.H. from Yale University. She received her M.D. from the Icahn School of Medicine at Mount Sinai, completed her internal medicine residency at the University of Pennsylvania, and also received an M.P.A. from Harvard’s John F. Kennedy School of Government. She is the former president of the Association of State and Territorial Health Officials.
Electra Paskett, Ph.D., is the Marion N. Rowley Professor of Cancer Research at The Ohio State University. She is also the director of the Division of Cancer Prevention and Control in the College of Medicine, a professor in the Division of Epidemiology, the associate director for population sciences and community outreach at the Comprehensive Cancer Center, and the director of the Center for Cancer Health Equity at The Ohio State University. Previously she was on the faculty of the Wake Forest University School of Medicine. She is a past president of the American Society of Preventive Oncology and was the chair of the American Public Health Association Cancer Forum. She is the deputy editor of Cancer, Epidemiology, Biomarkers and Prevention and has served on the editorial boards of Cancer Prevention Research and Cancer. She received her B.S. from The University of Utah and Ph.D. from the University of Washington. She is a recipient of the American Association for Cancer Research for Outstanding Achievement Award and the American Society of Preventive Oncology Distinguished Achievement Award. She is a fellow of the American Association for the Advancement of Science. She is a member of the National Cancer Advisory Board and has served as the president of the American Society of Preventive Oncology.
George Poste, Ph.D., D.V.M., is a Regent’s Professor and the Del E. Webb Chair of Health Innovation and the director and chief scientist of Complex Adaptive Systems at Arizona State University, where he was also the founding director of the Biodesign Institute. Previously he was the chief science and technology officer and president of research and development, among other leadership positions, at SmithKline Beecham (now GlaxoSmithKline). Earlier he was a principal cancer research scientist at Roswell Park Memorial Institute (now Roswell Park Comprehensive Cancer Center). He has served on the Defense Science Board and on boards of numerous companies, including Health Longevity, Inc., Haplogen GmbH, Synthetic Genomics, Caris Life Sciences (as vice-chair), Exelexis, Illumina, Maxygen, diaDexus (as chair; acquired by VaxGen), Structural Genomix (as chair; acquired by Eli Lilly), AdvancePCS (acquired by CVS), Bur-rill and Company, and Monsanto. He has been a trustee of the Gordon Research Conferences, Royal Society of Medicine Foundation, Institute
for Scientific Information, and BP Technology Advisory Council. He has served as a distinguished fellow at the Hoover Institution of Stanford University and on the board of medical governors of the World Economic Forum. He has received honorary doctorates from the University of Bristol (where he received his D.V.M. and Ph.D.) and the University of Dundee. His awards include the Global Business Leadership Forum’s Einstein Award and the Pharmaceutical Industry Leadership Forum’s Scrip Lifetime Achievement Award. He is a member of the Council on Foreign Relations and a fellow of the U.K. Royal College of Pathologists, the Royal College of Physicians, the Royal Society of Arts, the Academy of Medical Sciences, and the Royal Society. He is a Commander of the British Empire.
William Rouse, Ph.D., is the Alexander Crombie Humphreys Chair and the director of the Center for Complex Systems and Enterprises at Stevens Institute of Technology. Previously he was a professor in the School of Industrial and Systems Engineering at the Georgia Institute of Technology. He was the chief executive officer of two software companies—Enterprise Support Systems and Search Technology. He has held faculty positions at the University of Illinois, Delft University of Technology, and Tufts University. Among many advisory roles, he has served as a member of the U.S. Air Force Scientific Advisory Board and a member of the Department of Defense Senior Advisory Group on Modeling and Simulation. He has received the Joseph Wohl Outstanding Career Award and the Norbert Wiener Award from the IEEE (Institute of Electrical and Electronics Engineers) Systems, Man, and Cybernetics Society; a Centennial Medal and a Third Millennium Medal from IEEE; and the O. Hugo Schuck Award from the American Automation Control Council. He is a fellow of IEEE, the International Council on Systems Engineering, the Institute for Operations Research and Management Science, and the Human Factors and Ergonomics Society. He is a member of the National Academy of Engineering.
William Stead, M.D., is the chief strategy officer for Vanderbilt University Medical Center, where he also holds appointments as the McKesson Foundation Professor of Biomedical Informatics and Professor of Medicine. He has served as the president of the American College of Medical Informatics and the chair of the board of regents of the National Library of Medicine. He is a founding fellow of the American College of Medical Informatics and the American Institute for Medical and Biological Engineering, and he served as the founding editor-in-chief of the Journal of the American Medical Informatics Association. He received his B.A., M.D., and residency training in internal medicine and nephrology from Duke University. His awards include the Collen Award for Excellence in Medical Informatics and the Lindberg Award for Innovation in Informatics. He is
the chair of the National Committee on Vital and Health Statistics of the Department of Health and Human Services. He is a member and former councilor of the National Academy of Medicine.
Cornelia Ulrich, Ph.D., is the executive director of the Comprehensive Cancer Center at the Huntsman Cancer Institute and also the Jon M. and Karen Huntsman Presidential Professor in Cancer Research in the Department of Population Health Sciences at The University of Utah. Her research focuses on lifestyle and biologic factors in cancer prevention and cancer prognosis. She is also the principal investigator of the Huntsman Cancer Institute Total Cancer Care Protocol in the ORIEN network of cancer centers. Earlier she was the head of the Department of Preventive Oncology at the German Cancer Research Center and the director of the National Center for Tumor Diseases in Heidelberg, Germany. She has served as a co-chair of the German Society of Epidemiology cancer group and was a guest member of the committee for the implementation of the German Cancer Plan. She serves on numerous national and international advisory boards and leadership committees for groups, including the National Institutes of Health, the International Agency for Research on Cancer, and the American Association for Cancer Research. She is a senior editor for Cancer Epidemiology, Biomarkers, & Prevention. She received her M.Sc. from Oregon State University and Ph.D. from the University of Washington. She is a recipient of the American Association of Cancer Research Bristol-Myers Squibb Young Investigator Award, a former Fulbright scholar, and a member of the European Academy of Cancer Sciences.
Guru Madhavan, Ph.D. (Study Director), is the director of programs of the National Academy of Engineering. His portfolio of work at the National Academies of Sciences, Engineering, and Medicine has included leading the analyses for making prescription medicines affordable, directing a global health forum on infectious diseases, and conducting the research, design, and development of a systems analysis platform for prioritizing new vaccines. A systems engineer by background, he received his M.S. and Ph.D. in biomedical engineering and an M.B.A. from the State University of New York. He has served as a technical adviser to the Department of Health and Human Services and has worked in the medical device industry as a research scientist developing cardiac surgical catheters for ablation therapy. He has served as a vice president of the Institute of Electrical and Electronics Engineers (IEEE)-USA and was a founding member of the Global Young Academy. His honors include the
National Academies’ Innovator Award, National Academy of Medicine’s Cecil Medal, AAMI–Becton Dickinson Award for Professional Achievement, Washington Academy of Sciences’ Krupsaw Award for engineering sciences and education, and Professional Achievement Award from the Society of Asian Scientists and Engineers as well as being named a distinguished young scientist by the World Economic Forum. For his books and lectures, he has also received the IEEE-USA Award for Distinguished Literary Contributions Furthering Public Understanding and the Advancement of the Engineering Profession.
Francis Amankwah, M.P.H., is an associate program officer in the Health and Medicine Division of the National Academies of Sciences, Engineering, and Medicine. Earlier, he provided research support for two forums focused on global violence prevention and on public–private partnerships for global health and safety in the National Academies’ Board on Global Health. He also served as a research associate for the National Academies’ Board on Children, Youth, and Families, where he provided research support for two consensus studies focused on peer victimization and bullying and on fostering school success for English and dual-language learners. For his work at the National Academies, he has received the Mount Everest staff achievement award from the Health and Medicine Division. He earned his M.P.H. and a graduate certificate in global planning and international development from Virginia Tech. He was raised in Ghana and earned his B.S. degree in agricultural science from Kwame Nkrumah University of Science and Technology.
Annalee Gonzales is an administrative assistant with the Board on Health Care Services and the National Cancer Policy Forum at the National Academies of Sciences, Engineering, and Medicine. She previously served as a senior program assistant for two reports from the National Academies on peer victimization and bullying and on fostering school success for English and dual-language learners. Prior to joining the National Academies she worked as an editorial and administrative coordinator at the National Association for Bilingual Education. She earned her B.A. in communication from Trinity University.
Sharyl Nass, Ph.D., serves as the director of the Board on Health Care Services and the director of the National Cancer Policy Forum at the National Academies of Sciences, Engineering, and Medicine. To help enable the best possible care for all patients, the board engages independent, scholarly analysis of the organization, financing, effectiveness, workforce, and delivery of health care, with an emphasis on quality, cost, and accessibility. The National Cancer Policy Forum examines policy issues pertaining
to the entire continuum of cancer research and care. For 20 years, Dr. Nass has worked on a broad range of health and science policy topics, including the quality and safety of health care and clinical trials, developing technologies for precision medicine, and strategies for large-scale biomedical science. She received her B.S. and an M.S. from the University of Wisconsin–Madison, completed her Ph.D. at Georgetown University, and conducted postdoctoral research at the Johns Hopkins University School of Medicine and the Max Planck Institute in Germany. She has received the Cecil Medal for Excellence in Health Policy Research, a Distinguished Service Award from the National Academies, and the Institute of Medicine staff team achievement award as a team leader.